NDC product
TABLET · Elysium Pharmaceutical Ltd
NDC 14803-135 · Elysium Pharmaceutical Ltd
Key facts
| Product NDC | 14803-135 |
|---|---|
| Nonproprietary name | acetaminophen aspirin and caffeine |
| Substances | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Dosage form | TABLET |
| Labeler | Elysium Pharmaceutical Ltd |
| Product type | HUMAN OTC DRUG |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Jan 30, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: